(VIANEWS) – Shares of Zendesk (NYSE Composite: ZEN) slid 5.81% to $94.00 at 11:05 EST on Friday, after two sequential sessions in a row of gains. NYSE Composite is dropping 0.45% to $16,400.62, following the last session’s upward trend. This seems, so far, a somewhat negative trend trading session today.

Zendesk’s last close was $99.80, 40.1% below its 52-week high of $166.60.

Volume

Today’s last reported volume for Zendesk is 1009874 which is 61.87% below its average volume of 2648533.

Zendesk’s Sales

Zendesk’s sales growth is 27.9% for the ongoing quarter and 28.2% for the next.

Zendesk’s Revenue

Year-on-year quarterly revenue growth grew by 29%, now sitting on 1.16B for the twelve trailing months.

Zendesk’s Stock Yearly Top and Bottom Value

Zendesk’s stock is valued at $94.00 at 11:05 EST, way under its 52-week high of $166.60 and above its 52-week low of $92.00.

Zendesk’s Moving Average

Zendesk’s value is way below its 50-day moving average of $116.24 and way below its 200-day moving average of $129.89.

Previous days news about Zendesk (ZEN)

  • Jana partners urges zendesk to ditch surveymonkey deal. According to The Wall Street Journal on Tuesday, 30 November, "Jana Partners LLC owns a big stake in Zendesk Inc. and is urging the customer-service platform to abandon a deal it struck to buy the parent of web-survey company SurveyMonkey ."
  • Shareholder alert: kaskela law LLC announces investigation of zendesk, inc. (zen) and encourages ZEN shareholders to contact the firm. According to Benzinga on Tuesday, 30 November, "On October 28, 2021, Zendesk announced that it had entered into an agreement to acquire Momentive Global Inc. ("Momentive"). ", "The investigation seeks to determine whether the proposed transaction with Momentive as structured is fair to Zendesk and the company’s stockholders, and whether stockholders are being provided with all material information necessary to evaluate and vote on the proposed transaction."

More news about Zendesk (ZEN).

LEAVE A REPLY

Please enter your comment!
Please enter your name here